| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $142.7M | +55.6% |
| SG&A Expense | $45.5M | +46.1% |
| Operating Income | -$252.1M | -85.5% |
| Pre-tax Income | -$235.7M | -80.0% |
| Income Tax | $268K | — |
| Net Income | -$235.9M | -80.2% |
| EPS (Basic) | -$3.63 | +24.5% |
| EPS (Diluted) | -$3.63 | +24.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $374.0M | +55.2% |
| Short-term Investments | $79.9M | -38.9% |
| Current Assets | $478.3M | +23.3% |
| Total Assets | $496.2M | +16.4% |
| Current Liabilities | $25.1M | +6.0% |
| Total Liabilities | $27.1M | -7.7% |
| Stockholders' Equity | $469.1M | +205.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$163.3M | -42.1% |
| Capital Expenditures | $117K | -77.1% |
| Investing Cash Flow | $64.4M | +138.3% |
| Financing Cash Flow | $231.9M | +100.4% |
| Free Cash Flow | -$163.4M | -41.6% |